N-[[4-[[2-butyl-4-(tert-butylamino)imidazo[4,5-c]quinolin-1-yl]methyl]phenyl]methyl]-2-cyclopropylacetamide
C31H39N5O — CID 138645379
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-[[2-butyl-4-(tert-butylamino)imidazo[4,5-c]quinolin-1-yl]methyl]phenyl]methyl]-2-cyclopropylacetamide
N-[[4-[[2-butyl-4-(tert-butylamino)imidazo[4,5-c]quinolin-1-yl]methyl]phenyl]methyl]-2-cyclopropylacetamide (PubChem CID 138645379) has the molecular formula C31H39N5O and a molecular weight of 497.69 g/mol. Its IUPAC name is N-[[4-[[2-butyl-4-(tert-butylamino)imidazo[4,5-c]quinolin-1-yl]methyl]phenyl]methyl]-2-cyclopropylacetamide.
Molecular Properties
| Compound Name | N-[[4-[[2-butyl-4-(tert-butylamino)imidazo[4,5-c]quinolin-1-yl]methyl]phenyl]methyl]-2-cyclopropylacetamide |
|---|---|
| PubChem CID | 138645379 |
| Molecular Formula | C31H39N5O |
| Molecular Weight | 497.69 g/mol |
| Exact Mass | 497.32 |
| IUPAC Name | N-[[4-[[2-butyl-4-(tert-butylamino)imidazo[4,5-c]quinolin-1-yl]methyl]phenyl]methyl]-2-cyclopropylacetamide |
| SMILES | CCCCc1nc2c(NC(C)(C)C)nc3ccccc3c2n1Cc1ccc(CNC(=O)CC2CC2)cc1 |
| InChI | InChI=1S/C31H39N5O/c1-5-6-11-26-34-28-29(24-9-7-8-10-25(24)33-30(28)35-31(2,3)4)36(26)20-23-16-14-22(15-17-23)19-32-27(37)18-21-12-13-21/h7-10,14-17,21H,5-6,11-13,18-20H2,1-4H3,(H,32,37)(H,33,35) |
| InChIKey | NHIDCAHANFRIOL-UHFFFAOYSA-N |
| XLogP | 6.60 |
| TPSA | 71.84 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 497.69 |
| LogP ≤ 5 | 6.60 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138645379 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.